Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Summary
The global Oncology Biomarker Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
The Oncology Biomarker Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Oncology Biomarker Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- Abbott Laboratories
- Bristol-Myers Squibb
- Eli Lilly and Company
- F.Hoffmann-La Roche Ltd.
- Genomic Health
- GlaxoSmithKline plc
- Novartis AG
- Merck & Co.
- Pfizer
- Qiagen N.V.
By the Product Type, the market is primarily segmented into:
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Stomach Cancer
- Others
- Market segment by Application, split into
- Diagnostics
- Drug Discovery And Development
- Prognostics
- Risk Assessment
- Others
By Applications, the market is segmented into:
- Diagnostics
- Drug Discovery And Development
- Prognostics
- Risk Assessment
- Others
The Report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Oncology Biomarker Market Report:
- To assess the size of the market by value and volume
- Analyze the Oncology Biomarker Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Oncology Biomarker Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact growth of the Oncology Biomarker Market
The Oncology Biomarker Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Oncology Biomarker Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Oncology Biomarker Revenue
1.4 Market Analysis by Type
1.4.1 Global Oncology Biomarker Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Lung Cancer
1.4.3 Breast Cancer
1.4.4 Colorectal Cancer
1.4.5 Prostate Cancer
1.4.6 Stomach Cancer
1.4.7 Others
1.5 Market by Application
1.5.1 Global Oncology Biomarker Market Share by Application: 2020 VS 2026
1.5.2 Diagnostics
1.5.3 Drug Discovery And Development
1.5.4 Prognostics
1.5.5 Risk Assessment
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Oncology Biomarker Market Perspective (2015-2026)
2.2 Oncology Biomarker Growth Trends by Regions
2.2.1 Oncology Biomarker Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Oncology Biomarker Historic Market Share by Regions (2015-2020)
2.2.3 Oncology Biomarker Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Oncology Biomarker Market Growth Strategy
2.3.6 Primary Interviews with Key Oncology Biomarker Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Oncology Biomarker Players by Market Size
3.1.1 Global Top Oncology Biomarker Players by Revenue (2015-2020)
3.1.2 Global Oncology Biomarker Revenue Market Share by Players (2015-2020)
3.1.3 Global Oncology Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Oncology Biomarker Market Concentration Ratio
3.2.1 Global Oncology Biomarker Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Oncology Biomarker Revenue in 2019
3.3 Oncology Biomarker Key Players Head office and Area Served
3.4 Key Players Oncology Biomarker Product Solution and Service
3.5 Date of Enter into Oncology Biomarker Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Oncology Biomarker Historic Market Size by Type (2015-2020)
4.2 Global Oncology Biomarker Forecasted Market Size by Type (2021-2026)
5 Oncology Biomarker Breakdown Data by Application (2015-2026)
5.1 Global Oncology Biomarker Market Size by Application (2015-2020)
5.2 Global Oncology Biomarker Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Oncology Biomarker Market Size (2015-2020)
6.2 Oncology Biomarker Key Players in North America (2019-2020)
6.3 North America Oncology Biomarker Market Size by Type (2015-2020)
6.4 North America Oncology Biomarker Market Size by Application (2015-2020)
7 Europe
7.1 Europe Oncology Biomarker Market Size (2015-2020)
7.2 Oncology Biomarker Key Players in Europe (2019-2020)
7.3 Europe Oncology Biomarker Market Size by Type (2015-2020)
7.4 Europe Oncology Biomarker Market Size by Application (2015-2020)
8 China
8.1 China Oncology Biomarker Market Size (2015-2020)
8.2 Oncology Biomarker Key Players in China (2019-2020)
8.3 China Oncology Biomarker Market Size by Type (2015-2020)
8.4 China Oncology Biomarker Market Size by Application (2015-2020)
9 Japan
9.1 Japan Oncology Biomarker Market Size (2015-2020)
9.2 Oncology Biomarker Key Players in Japan (2019-2020)
9.3 Japan Oncology Biomarker Market Size by Type (2015-2020)
9.4 Japan Oncology Biomarker Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Oncology Biomarker Market Size (2015-2020)
10.2 Oncology Biomarker Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Oncology Biomarker Market Size by Type (2015-2020)
10.4 Southeast Asia Oncology Biomarker Market Size by Application (2015-2020)
11 India
11.1 India Oncology Biomarker Market Size (2015-2020)
11.2 Oncology Biomarker Key Players in India (2019-2020)
11.3 India Oncology Biomarker Market Size by Type (2015-2020)
11.4 India Oncology Biomarker Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Oncology Biomarker Market Size (2015-2020)
12.2 Oncology Biomarker Key Players in Central & South America (2019-2020)
12.3 Central & South America Oncology Biomarker Market Size by Type (2015-2020)
12.4 Central & South America Oncology Biomarker Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
13.1.3 Abbott Laboratories Oncology Biomarker Introduction
13.1.4 Abbott Laboratories Revenue in Oncology Biomarker Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Bristol-Myers Squibb
13.2.1 Bristol-Myers Squibb Company Details
13.2.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.2.3 Bristol-Myers Squibb Oncology Biomarker Introduction
13.2.4 Bristol-Myers Squibb Revenue in Oncology Biomarker Business (2015-2020)
13.2.5 Bristol-Myers Squibb Recent Development
13.3 Eli Lilly and Company
13.3.1 Eli Lilly and Company Company Details
13.3.2 Eli Lilly and Company Business Overview and Its Total Revenue
13.3.3 Eli Lilly and Company Oncology Biomarker Introduction
13.3.4 Eli Lilly and Company Revenue in Oncology Biomarker Business (2015-2020)
13.3.5 Eli Lilly and Company Recent Development
13.4 F.Hoffmann-La Roche Ltd.
13.4.1 F.Hoffmann-La Roche Ltd. Company Details
13.4.2 F.Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue
13.4.3 F.Hoffmann-La Roche Ltd. Oncology Biomarker Introduction
13.4.4 F.Hoffmann-La Roche Ltd. Revenue in Oncology Biomarker Business (2015-2020)
13.4.5 F.Hoffmann-La Roche Ltd. Recent Development
13.5 Genomic Health
13.5.1 Genomic Health Company Details
13.5.2 Genomic Health Business Overview and Its Total Revenue
13.5.3 Genomic Health Oncology Biomarker Introduction
13.5.4 Genomic Health Revenue in Oncology Biomarker Business (2015-2020)
13.5.5 Genomic Health Recent Development
13.6 GlaxoSmithKline plc
13.6.1 GlaxoSmithKline plc Company Details
13.6.2 GlaxoSmithKline plc Business Overview and Its Total Revenue
13.6.3 GlaxoSmithKline plc Oncology Biomarker Introduction
13.6.4 GlaxoSmithKline plc Revenue in Oncology Biomarker Business (2015-2020)
13.6.5 GlaxoSmithKline plc Recent Development
13.7 Novartis AG
13.7.1 Novartis AG Company Details
13.7.2 Novartis AG Business Overview and Its Total Revenue
13.7.3 Novartis AG Oncology Biomarker Introduction
13.7.4 Novartis AG Revenue in Oncology Biomarker Business (2015-2020)
13.7.5 Novartis AG Recent Development
13.8 Merck & Co.
13.8.1 Merck & Co. Company Details
13.8.2 Merck & Co. Business Overview and Its Total Revenue
13.8.3 Merck & Co. Oncology Biomarker Introduction
13.8.4 Merck & Co. Revenue in Oncology Biomarker Business (2015-2020)
13.8.5 Merck & Co. Recent Development
13.9 Pfizer
13.9.1 Pfizer Company Details
13.9.2 Pfizer Business Overview and Its Total Revenue
13.9.3 Pfizer Oncology Biomarker Introduction
13.9.4 Pfizer Revenue in Oncology Biomarker Business (2015-2020)
13.9.5 Pfizer Recent Development
13.10 Qiagen N.V.
13.10.1 Qiagen N.V. Company Details
13.10.2 Qiagen N.V. Business Overview and Its Total Revenue
13.10.3 Qiagen N.V. Oncology Biomarker Introduction
13.10.4 Qiagen N.V. Revenue in Oncology Biomarker Business (2015-2020)
13.10.5 Qiagen N.V. Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Table
List of Tables
Table 1. Oncology Biomarker Key Market Segments
Table 2. Key Players Covered: Ranking by Oncology Biomarker Revenue
Table 3. Ranking of Global Top Oncology Biomarker Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Oncology Biomarker Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Lung Cancer
Table 6. Key Players of Breast Cancer
Table 7. Key Players of Colorectal Cancer
Table 8. Key Players of Prostate Cancer
Table 9. Key Players of Stomach Cancer
Table 10. Key Players of Others
Table 11. Global Oncology Biomarker Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Oncology Biomarker Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Oncology Biomarker Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Oncology Biomarker Market Share by Regions (2015-2020)
Table 15. Global Oncology Biomarker Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Oncology Biomarker Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Oncology Biomarker Market Growth Strategy
Table 21. Main Points Interviewed from Key Oncology Biomarker Players
Table 22. Global Oncology Biomarker Revenue by Players (2015-2020) (Million US$)
Table 23. Global Oncology Biomarker Market Share by Players (2015-2020)
Table 24. Global Top Oncology Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Biomarker as of 2019)
Table 25. Global Oncology Biomarker by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Oncology Biomarker Product Solution and Service
Table 28. Date of Enter into Oncology Biomarker Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Oncology Biomarker Market Size by Type (2015-2020) (Million US$)
Table 31. Global Oncology Biomarker Market Size Share by Type (2015-2020)
Table 32. Global Oncology Biomarker Revenue Market Share by Type (2021-2026)
Table 33. Global Oncology Biomarker Market Size Share by Application (2015-2020)
Table 34. Global Oncology Biomarker Market Size by Application (2015-2020) (Million US$)
Table 35. Global Oncology Biomarker Market Size Share by Application (2021-2026)
Table 36. North America Key Players Oncology Biomarker Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Oncology Biomarker Market Share (2019-2020)
Table 38. North America Oncology Biomarker Market Size by Type (2015-2020) (Million US$)
Table 39. North America Oncology Biomarker Market Share by Type (2015-2020)
Table 40. North America Oncology Biomarker Market Size by Application (2015-2020) (Million US$)
Table 41. North America Oncology Biomarker Market Share by Application (2015-2020)
Table 42. Europe Key Players Oncology Biomarker Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Oncology Biomarker Market Share (2019-2020)
Table 44. Europe Oncology Biomarker Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Oncology Biomarker Market Share by Type (2015-2020)
Table 46. Europe Oncology Biomarker Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Oncology Biomarker Market Share by Application (2015-2020)
Table 48. China Key Players Oncology Biomarker Revenue (2019-2020) (Million US$)
Table 49. China Key Players Oncology Biomarker Market Share (2019-2020)
Table 50. China Oncology Biomarker Market Size by Type (2015-2020) (Million US$)
Table 51. China Oncology Biomarker Market Share by Type (2015-2020)
Table 52. China Oncology Biomarker Market Size by Application (2015-2020) (Million US$)
Table 53. China Oncology Biomarker Market Share by Application (2015-2020)
Table 54. Japan Key Players Oncology Biomarker Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Oncology Biomarker Market Share (2019-2020)
Table 56. Japan Oncology Biomarker Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Oncology Biomarker Market Share by Type (2015-2020)
Table 58. Japan Oncology Biomarker Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Oncology Biomarker Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Oncology Biomarker Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Oncology Biomarker Market Share (2019-2020)
Table 62. Southeast Asia Oncology Biomarker Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Oncology Biomarker Market Share by Type (2015-2020)
Table 64. Southeast Asia Oncology Biomarker Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Oncology Biomarker Market Share by Application (2015-2020)
Table 66. India Key Players Oncology Biomarker Revenue (2019-2020) (Million US$)
Table 67. India Key Players Oncology Biomarker Market Share (2019-2020)
Table 68. India Oncology Biomarker Market Size by Type (2015-2020) (Million US$)
Table 69. India Oncology Biomarker Market Share by Type (2015-2020)
Table 70. India Oncology Biomarker Market Size by Application (2015-2020) (Million US$)
Table 71. India Oncology Biomarker Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Oncology Biomarker Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Oncology Biomarker Market Share (2019-2020)
Table 74. Central & South America Oncology Biomarker Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Oncology Biomarker Market Share by Type (2015-2020)
Table 76. Central & South America Oncology Biomarker Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Oncology Biomarker Market Share by Application (2015-2020)
Table 78. Abbott Laboratories Company Details
Table 79. Abbott Laboratories Business Overview
Table 80. Abbott Laboratories Product
Table 81. Abbott Laboratories Revenue in Oncology Biomarker Business (2015-2020) (Million US$)
Table 82. Abbott Laboratories Recent Development
Table 83. Bristol-Myers Squibb Company Details
Table 84. Bristol-Myers Squibb Business Overview
Table 85. Bristol-Myers Squibb Product
Table 86. Bristol-Myers Squibb Revenue in Oncology Biomarker Business (2015-2020) (Million US$)
Table 87. Bristol-Myers Squibb Recent Development
Table 88. Eli Lilly and Company Company Details
Table 89. Eli Lilly and Company Business Overview
Table 90. Eli Lilly and Company Product
Table 91. Eli Lilly and Company Revenue in Oncology Biomarker Business (2015-2020) (Million US$)
Table 92. Eli Lilly and Company Recent Development
Table 93. F.Hoffmann-La Roche Ltd. Company Details
Table 94. F.Hoffmann-La Roche Ltd. Business Overview
Table 95. F.Hoffmann-La Roche Ltd. Product
Table 96. F.Hoffmann-La Roche Ltd. Revenue in Oncology Biomarker Business (2015-2020) (Million US$)
Table 97. F.Hoffmann-La Roche Ltd. Recent Development
Table 98. Genomic Health Company Details
Table 99. Genomic Health Business Overview
Table 100. Genomic Health Product
Table 101. Genomic Health Revenue in Oncology Biomarker Business (2015-2020) (Million US$)
Table 102. Genomic Health Recent Development
Table 103. GlaxoSmithKline plc Company Details
Table 104. GlaxoSmithKline plc Business Overview
Table 105. GlaxoSmithKline plc Product
Table 106. GlaxoSmithKline plc Revenue in Oncology Biomarker Business (2015-2020) (Million US$)
Table 107. GlaxoSmithKline plc Recent Development
Table 108. Novartis AG Company Details
Table 109. Novartis AG Business Overview
Table 110. Novartis AG Product
Table 111. Novartis AG Revenue in Oncology Biomarker Business (2015-2020) (Million US$)
Table 112. Novartis AG Recent Development
Table 113. Merck & Co. Business Overview
Table 114. Merck & Co. Product
Table 115. Merck & Co. Company Details
Table 116. Merck & Co. Revenue in Oncology Biomarker Business (2015-2020) (Million US$)
Table 117. Merck & Co. Recent Development
Table 118. Pfizer Company Details
Table 119. Pfizer Business Overview
Table 120. Pfizer Product
Table 121. Pfizer Revenue in Oncology Biomarker Business (2015-2020) (Million US$)
Table 122. Pfizer Recent Development
Table 123. Qiagen N.V. Company Details
Table 124. Qiagen N.V. Business Overview
Table 125. Qiagen N.V. Product
Table 126. Qiagen N.V. Revenue in Oncology Biomarker Business (2015-2020) (Million US$)
Table 127. Qiagen N.V. Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Biomarker Market Share by Type: 2020 VS 2026
Figure 2. Lung Cancer Features
Figure 3. Breast Cancer Features
Figure 4. Colorectal Cancer Features
Figure 5. Prostate Cancer Features
Figure 6. Stomach Cancer Features
Figure 7. Others Features
Figure 8. Global Oncology Biomarker Market Share by Application: 2020 VS 2026
Figure 9. Diagnostics Case Studies
Figure 10. Drug Discovery And Development Case Studies
Figure 11. Prognostics Case Studies
Figure 12. Risk Assessment Case Studies
Figure 13. Others Case Studies
Figure 14. Oncology Biomarker Report Years Considered
Figure 15. Global Oncology Biomarker Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Oncology Biomarker Market Share by Regions: 2020 VS 2026
Figure 17. Global Oncology Biomarker Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Oncology Biomarker Market Share by Players in 2019
Figure 20. Global Top Oncology Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Biomarker as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Oncology Biomarker Revenue in 2019
Figure 22. North America Oncology Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Oncology Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Oncology Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Oncology Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Oncology Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Oncology Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Oncology Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Abbott Laboratories Revenue Growth Rate in Oncology Biomarker Business (2015-2020)
Figure 31. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Bristol-Myers Squibb Revenue Growth Rate in Oncology Biomarker Business (2015-2020)
Figure 33. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Eli Lilly and Company Revenue Growth Rate in Oncology Biomarker Business (2015-2020)
Figure 35. F.Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. F.Hoffmann-La Roche Ltd. Revenue Growth Rate in Oncology Biomarker Business (2015-2020)
Figure 37. Genomic Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Genomic Health Revenue Growth Rate in Oncology Biomarker Business (2015-2020)
Figure 39. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. GlaxoSmithKline plc Revenue Growth Rate in Oncology Biomarker Business (2015-2020)
Figure 41. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Novartis AG Revenue Growth Rate in Oncology Biomarker Business (2015-2020)
Figure 43. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Merck & Co. Revenue Growth Rate in Oncology Biomarker Business (2015-2020)
Figure 45. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Pfizer Revenue Growth Rate in Oncology Biomarker Business (2015-2020)
Figure 47. Qiagen N.V. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Qiagen N.V. Revenue Growth Rate in Oncology Biomarker Business (2015-2020)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
